CINECA IRIS Institutional Research Information System

Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trial.

DI PERRI, Giovanni;
2011-01-01
2011
HIV CLINICAL TRIALS
12
24
36
http://dx.doi.org/10.1310/hct1201-24
Adult, Anti-HIV Agents; administration /&/ dosage, Benzoxazines; administration /&/ dosage, Chi-Square Distribution, Cholesterol; blood, Cyclohexanes; administration /&/ dosage, Dyslipidemias; blood/drug therapy/virology, Female, HIV Infections; blood/drug therapy/virology, HIV-1; isolation /&/ purification, Humans, Lipid Metabolism; drug effects, Male, Receptors; CCR5; antagonists /&/ inhibitors/metabolism, Triazoles; administration /&/ dosage, Triglycerides; blood
A. MacInnes;A. Lazzarin;G. Di Perri;J. G. Sierra-Madero;J. Aberg;J. Heera;N. Rajicic;J. Goodrich;H. Mayer;H. Valdez
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/98407
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 40
social impact